Anticancer (cytotoxic, anticlonogenic, antimetastatic, immunomodulatory actions) properties of 3,5‐dibromosalicylaldehyde against glioblastoma cells and DFT analyses (FT‐IR, Raman, NMR, UV) as well as a molecular docking study
Biology of the Cell,
Journal Year:
2025,
Volume and Issue:
117(2)
Published: Feb. 1, 2025
The
primary
objectives
of
this
study
were
to
characterize
3,5-dibromosalicylaldehyde
(3,5-DBSA)
and,
investigate
its
antiproliferative,
antimetastatic,
cytotoxic,
and
immunoregulatory
properties.
NMR,
Raman,
UV,
FT-IR
spectroscopies
used
3,5-DBSA.
Potential
conformations
3,5-DBSA
evaluated
using
Spartan's
MMFF
method.
Geometry
optimization
calculations
Gaussian
software
calculated
conformation
energy
values.
Subsequently,
FT-IR,
UV
(ethanol)
NMR
(DMSO)
parameters
calculated.
experimental
spectrum
was
compared
theoretical
spectroscopic
data.
present
investigation
investigated
3,5-DBSA's
anticancer
properties;
therefore,
docking
done
once
the
stable
structure
had
been
identified.
Identifying
is
crucial
molecular
studies.
In
order
identify
mechanism
by
which
binds
PI3K
as
a
therapeutic
target,
utilized.
This
work
first
show
that
anticlonogenic,
immunomodulatory
in
glioblastoma
cell
line
U87MG
healthy
fibroblast
L929
cells.
Cytotoxicity
anti-clonogenicity
studies
antiproliferative
activities,
whereas
wound
healing
assays
assessed
migration.
effects
measuring
Netrin-1
IL-6
protein
levels.
According
our
findings,
may
treat
glioblastoma.
analyzes
conformational
search,
characterization,
docking,
structural
Language: Английский
New Hydrazide-Hydrazone Derivatives Containing Coumarin and Indole Moiety: Synthesis, Spectroscopic Characterization and DFT Studies
Journal of Molecular Structure,
Journal Year:
2024,
Volume and Issue:
unknown, P. 140237 - 140237
Published: Sept. 1, 2024
Language: Английский
The impact of Bromine substitution on molecular structure and spectroscopic properties of (E)-3-(2-phenylhydrazineylidene) chromane-2, 4-dione
Tarun Yadav,
No information about this author
Indrajit Karmakar,
No information about this author
A.K. Vishwkarma
No information about this author
et al.
Journal of the Indian Chemical Society,
Journal Year:
2024,
Volume and Issue:
unknown, P. 101531 - 101531
Published: Dec. 1, 2024
Language: Английский
Spectroscopic Characterization, Quantum Chemical, Molecular Docking, Antibacterial and Anticancer Studies on Ethyl Coumarin-3-Carboxylate: an Antibacterial and Lung Cancer Agent
S. Mohan,
No information about this author
M. R. Meera,
No information about this author
A. Rathika
No information about this author
et al.
Polycyclic aromatic compounds,
Journal Year:
2023,
Volume and Issue:
unknown, P. 1 - 17
Published: Nov. 9, 2023
The
detailed
theoretical
and
experimental
(FT-IR,
FT-Raman,
UV-visible)
spectroscopy
analyses
of
the
Ethyl
Coumarin-3-Carboxylate
(ECC)
molecule
were
carried
out.
ECC
compound’s
pharmacological
properties
also
investigated,
utilizing
antibacterial
anticancer
activity
investigations.
Initially,
was
optimized
by
density
functional
theory
B3LYP
method
with
a
6-311
G++
(d,p)
basis
set
using
Gaussian
09
W
program.
molecular
structure
provides
harmonic
vibrational
frequencies
molecule.
observed
computed
wavenumbers
assigned
found
to
be
well
correlated.
UV-Vis
absorption
spectrum
analysis
indicates
that
contains
π
→π*
n
→
π*
electronic
transitions.
Frontier
orbital
confirmed
reactivity
bioactivity
ECC,
while
Mulliken
atomic
charge
distribution
pinpointed
molecule’s
reactive
sites.
Antibacterial
testing
demonstrated
inhibitory
effect
on
various
bacterial
strains,
particular
impact
Klebsiella
pneumonia.
In
vitro,
assessments
showcased
ECC's
stronger
effects
A549
lung
cancer
cell
lines
compared
HeLa
cervical
lines.
Additionally,
in
silico
docking
investigations
provided
further
validation
compound
can
inhibit
function
epidermal
growth
factor
receptor,
associated
cancer.
As
result,
this
study
lays
foundation
for
development
novel
drugs
treatment.
Language: Английский